CCL2 as a potential therapeutic target for clear cell renal cell carcinoma

We previously reported that the pVHL‐atypical PKC‐JunB pathway contributed to promotion of cell invasiveness and angiogenesis in clear cell renal cell carcinoma (ccRCC), and we detected chemokine (C‐C motif) ligand‐2 (CCL2) as one of downstream effectors of JunB. CCL2 plays a critical role in tumori...

Descripción completa

Detalles Bibliográficos
Autores principales: Arakaki, Ryuichiro, Yamasaki, Toshinari, Kanno, Toru, Shibasaki, Noboru, Sakamoto, Hiromasa, Utsunomiya, Noriaki, Sumiyoshi, Takayuki, Shibuya, Shinsuke, Tsuruyama, Tatsuaki, Nakamura, Eijiro, Ogawa, Osamu, Kamba, Tomomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083746/
https://www.ncbi.nlm.nih.gov/pubmed/27666332
http://dx.doi.org/10.1002/cam4.886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083746/
https://www.ncbi.nlm.nih.gov/pubmed/27666332
http://dx.doi.org/10.1002/cam4.886

Ejemplares similares